Thermo Fisher Scientific Inc. is proposing to build a new “corporate hangar and office facility” at the Portsmouth ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Seer (SEER) announced a co-marketing and sales agreement with Thermo Fisher (TMO) to jointly promote Seer’s Proteograph Product Suite ...

The collaboration agreement will enable Mainz Biomed and Thermo Fisher to jointly develop and potentially commercialize Mainz Biomed’s Next Generation colorectal cancer screening product. The ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Under the terms of this new nonexclusive agreement, Thermo Fisher’s global sales force will be able to quote and sell the ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor ...

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 ...

Thermo Fisher (NYSE:TMO) reported $10.6B in revenue for the quarter, mostly unchanged from last year and missing the consensus by $30M as its main revenue generator, Laboratory Products ...

Thermo Fisher Scientific TMO is preparing to release ... analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services ...

(Reuters) - Thermo Fisher Scientific on Wednesday raised the ... For the third quarter, sales in the company's laboratory products segment that provides products and services used in clinical ...